A bandage to treat skin cancer

Feature_Pharma_RadioctiveSun lovers are bombarded daily by warnings about the cancer dangers posed by their passion.

But researchers now are offering hope to patients with skin cancer that they could be treated one day with a radioactive bandage containing exactly the right dosage to shrink tumor lesions.

Researchers say such a bandage s could be used as an alternative or complement to external beam radiation and surgery.

The bandage easily could be adjusted to fit the size and position of the tumor lesion and would make it possible to treat skin cancer without harming healthy tissue, said Anthony Di Pasqua, PhD, Assistant Professor of Pharmaceutical Sciences at UNT Health Science Center.

“We know that such a bandage can be used to shrink tumors,” he said. “But the goal is to use a much lower dosage of radiation than what patients are exposed to now.”

Radiation therapy uses a beam of electrons that only penetrates as far as the skin. It is sometimes used to treat squamous and basal cell carcinoma, which affects more than 3.5 million people in the United States.

Radioactive skin bandages have not been tested in human clinical trials. Dr. Di Pasqua and his colleague, Kenneth J. Balkus, PhD, at UT Dallas, hope to publish preliminary results of their research this winter.

Dr. Di Pasqua said that the bandage streamlines treatment and ensures that the patient receives a therapeutic dosage. It is composed of holmium-containing nanoparticles that become radioactive upon bombardment by neurons.

By using short-lived isotopes, the bandage is no longer radioactive after 11 days, Dr. Di Pasqua said. During treatment, bandaged patients would be confined to an outpatient clinic, where a lead shield would prevent others from being exposed to radiation. Radioactive sensitizers make it possible to use lower doses of radiation than are normally given in hospitals or clinics.

The length of time the patient would be exposed to radiation would be calculated down to the second.

In some patients, a single dose of radiation may be enough to shrink a tumor, but others may require multiple doses.

“Being able to actually apply it to the skin is quite an elegant solution to this type of cancer,” he said.

Recent News

Phillips
  • Community
|May 1, 2024

2024 Faculty Achievement Award winner named

On Wednesday, Dr. Nicole Phillips, assistant professor, microbiology, immunology and genetics, in the School of Biomedical Sciences was awarded The University of North Texas Health Science Center at Fort Worth’s prestigious Faculty Achievement Award. The Faculty Achievement Award Committee annual...
76a95dd2 2f65 4897 93fc Eaffefda2010
  • Our People
|May 1, 2024

Faculty highlight: Dr. Michael Smith

Prior to joining The University of North Texas Health Science Center at Fort Worth, Dr. Michael L Smith was an assistant professor in cardiology at Case Western Reserve University School of Medicine. Currently, he serves as the Texas College of Osteopathic Medicine year 1 curriculum director, direct...
C5a978de 26df 4bc3 895f 2f54af3be037
  • Our People
|Apr 30, 2024

Faculty highlight: Dr. Collin O'Hara

Dr. O’Hara is the year 2 curriculum director and a pathology medical educator at The University of North Texas Health Science Center at Fort Worth’s Texas College of Osteopathic Medicine. Her research focuses on the effectiveness of multidisciplinary team teaching and active learning strategies ...
Yockey 1 768x994
  • Our People
|Apr 30, 2024

Faculty Highlight: Dr. Andrew Yockey

Dr. Yockey is an assistant professor, population and community health, at The University of North Texas Health Science Center’s School of Public Health, with a joint appointment as assistant professor for TCOM’s department of internal medicine and geriatrics. He recently served as a plenary spea...